Previous 10 | Next 10 |
Puhui Wealth Investment (NASDAQ:PHCF) +55%. Red Cat Holdings RCAT +50% after subsidiary receives five-year contract with NASA Paltalk (NASDAQ:PALT) +36%. Vinco Ventures (NASDAQ:BBIG) +16%. VIZIO Holding (NYSE:VZIO) +10%. U.S. Energy (NASDAQ:USEG) +8%. Syndax Pharmaceuticals (NASDAQ:...
Posting the third consecutive weekly loss, the healthcare stocks in the S&P 500 fell ~0.4% over the week. While healthcare became the fourth worst performing sector, the broader index edged ~0.5% higher during the week. Among healthcare stocks with more than $300M market cap and...
These 5 Penny Stocks Climbed Today, Are They On Your Watchlist? On September 23rd, many penny stocks and blue chips managed to climb by midday. This is the result of early-week bearish sentiment and a resulting bullish turnaround. If you’ve invested in penny stocks in the pas...
MEDIROM Healthcare Technologies (NASDAQ:MRM) +77% on deal for ZACC Kabushiki Kaisha Digital Brands (NASDAQ:DBGI) +27%. TransCode Therapeutics (NASDAQ:RNAZ) +15% announces publication in cancer nanotechnology of preclinical data supporting therapeutic potential of TTX-MC138 in m...
– Ms. Corzo brings a 25+ year successful track record in biopharma, excelling in oncology drug development with Takeda, Sanofi Genzyme, and Eli Lilly – BEDMINSTER, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clin...
A recent data announcement has spruced up MTNB stock. The stock was down since February on a trial miss. The trial miss, however, wasn't really as bad as the market assumed. For further details see: Matinas: Positive Trial Data Has This Stock On The Move
Gainers: Communications Systems (NASDAQ:JCS) +33%. BELLUS Health (NASDAQ:BLU) +20%. Matinas BioPharma (NYSE:MTNB) +19%. Onion Global (NYSE:OG) +18%. FuelCell Energy (NASDAQ:FCEL) +17%. Silverback Therapeutics (NASDAQ:SBTX) +16%. DatChat (NASDAQ:DATS) +15%. Calumet (NASDAQ:CLMT) +15%. Ada...
Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Bi...
BEDMINSTER, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, presented a Company overview at the H.C. Wainwright 23 rd Annual Global Investment Conference being held virtuall...
Are Cheap Penny Stocks Really Worth The Risk? Penny stocks are well-known for their high risk and high reward potential. In the stock market today there are hundreds of companies that fall under this definition of stocks under $5 but it also begs the question: is the risk worth it? In m...
News, Short Squeeze, Breakout and More Instantly...
Matinas Biopharma Holdings Inc. Company Name:
MTNB Stock Symbol:
NYSE Market:
Matinas Biopharma Holdings Inc. Website:
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces new in vitro data ...